Oncology

Cancer 01 Jan 2013

XK469 in Treating Patients With Advanced Solid Tumors or Lymphoma

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.PURPOSE: Phase I trial to study the effectiveness of XK469 in…
Cancer 01 Jan 2013

“REDUCE” – A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

Purpose This 4-year study will compare how safe and effective an oral investigational medicine is (compared to placebo) in preventing the development of prostate cancer in men that are defined by the study entrance criteria as being at an increased risk for prostate cancer. Study visits to the clinic…
Cancer 01 Jan 2013

Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow

Purpose The are a variety of cancerous diseases of the blood and bone marrow that can be potentially cured by bone marrow transplantation (BMT). Diseases like leukemia, lymphoma, and multiple myeloma are among the conditions that can be treated with BMT. Official Title Non-myeloablative Allogeneic Peripheral Blood Mobilized Hematopoietic…
Cancer 01 Jan 2013

LIPID (Long-term Intervention with Pravastatin in Ischaemic Disease)

LIPID (Long-term Intervention with Pravastatin in Ischaemic Disease) was a large multicentre trial begun in 1990, of the effects of pravastatin in 9014 patients with coronary heart disease and average cholesterol levels. The randomised phase of the trial finished in 1997 and the results, published in 1998 in the New…
Intensified chemotherapy shows promise for children with very high-risk form of leukaemia
Blood 21 Dec 2012

Intensified chemotherapy shows promise for children with very high-risk form of leukaemia

Young patients with an aggressive form of leukaemia who are likely to relapse after chemotherapy treatment can significantly reduce those odds by receiving additional courses of chemotherapy, suggest the findings of a clinical trial led by investigators at Dana-Farber/Children’s Hospital Cancer Center in Boston. The trial leaders will present the…
Treating childhood cancer in developing countries less expensive than believed
Cancer 10 Dec 2012

Treating childhood cancer in developing countries less expensive than believed

The assumption that childhood cancer in developing countries is prohibitively expensive to treat is challenged by new research contributed to by the University of Sydney. “Our findings mean it is time to re-evaluate global health policy,” said Dr Alexandra Martiniuk from the University’s School of Public Health and The George…
Nanomedicine hope for childhood cancer
Cancer 03 Dec 2012

Nanomedicine hope for childhood cancer

Researchers from UNSW’s Australian Centre for Nanomedicine have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five. Neuroblastoma is an aggressive childhood cancer that often leaves survivors with lingering health problems due to the high doses of chemotherapy required for treatment. Anything…
Breast cancer: Invasive breast carcinoma
Cancer 11 Sep 2012

Breast cancer: Invasive breast carcinoma

Breast cancer originates in the milk ducts or milk-producing tissue of the breasts. Invasive breast carcinoma invades normal healthy tissues.
Treatments for Renal Cell Cancer (RCC)
Cancer 05 Jul 2012

Treatments for Renal Cell Cancer (RCC)

Kidney cancer or renal cell carcinoma can be treated with nephrectomy (surgical kidney removal), chemotherapy and targeted cancer therapy.